Prior evidence has implicated a key role for BRD4 inhibition in multiple tumor states, including G3MB47,48,51,64 among many others, where dominant phenotypic outcomes on transcription were related to disruption of MYC transcription. This evidence concerns the gene BRD4 and neoplasm.